Literature DB >> 16076612

Genetic epidemiology of familial amyloid polyneuropathy in the Balearic Islands (Spain).

Miguel Munar-Qués1, Maria J M Saraiva, Carlos Viader-Farré, José María Zabay-Becerril, Juana Mulet-Ferrer.   

Abstract

Between 1976 and 2003, we diagnosed 144 patients with familial amyloid polyneuropathy (FAP) in the Balearic Islands (Spain). Analysis of genetic epidemiological data from 102 confirmed patients showed 62% were men. Parental transmission was paternal in 38, maternal in 25, and unknown in 39. No family history of FAP was found in 32 patients. TTRVal30Met associated with haplotype I was present in the individuals studied. Mean age-at-onset was 45.7 years which lies between that of Sweden and those of Portugal, Japan and Brazil. Duration of FAP was of 9.7 years. Age-at-onset, age-at-death, duration and fertility were similar between sexes. Twenty-nine intergeneration familial pairs of patients were ascertained. Raw anticipation was positive in twenty-four pairs, zero in one, and negative in four. Differences greater than 9 years between age-at-onset of the first and second member were considered relevant; positive relevant anticipation was found in 76% of the whole pairs. The frequency of positive anticipation of parent-child pairs was not significantly different than those described in the Swedish and Portuguese series. Significant positive correlation in age-at-onset was confirmed in twenty-seven types of pairs supporting the hypothesis that a genetic factor may modulate age-at-onset. The Balearic focus of FAP is expanding and constitutes a public health problem.

Entities:  

Mesh:

Year:  2005        PMID: 16076612     DOI: 10.1080/13506120500032741

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  12 in total

Review 1.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

2.  A Trans-acting Factor May Modify Age at Onset in Familial Amyloid Polyneuropathy ATTRV30M in Portugal.

Authors:  Miguel Alves-Ferreira; Teresa Coelho; Diana Santos; Jorge Sequeiros; Isabel Alonso; Alda Sousa; Carolina Lemos
Journal:  Mol Neurobiol       Date:  2017-05-19       Impact factor: 5.590

3.  Accessibility to Occupational Therapy Services for Hereditary Transthyretin Amyloidosis.

Authors:  Aina Gayà-Barroso; Juan González-Moreno; Adrián Rodríguez; Tomás Ripoll-Vera; Inés Losada-López; Margarita Gili; Eugenia Cisneros-Barroso
Journal:  Int J Environ Res Public Health       Date:  2022-04-07       Impact factor: 4.614

4.  Familial amyloid polyneuropathy in Portugal: New genes modulating age-at-onset.

Authors:  Diana Santos; Teresa Coelho; Miguel Alves-Ferreira; Jorge Sequeiros; Denisa Mendonça; Isabel Alonso; Carolina Lemos; Alda Sousa
Journal:  Ann Clin Transl Neurol       Date:  2016-12-20       Impact factor: 4.511

5.  C1QA and C1QC modify age-at-onset in familial amyloid polyneuropathy patients.

Authors:  Andreia Dias; Diana Santos; Teresa Coelho; Miguel Alves-Ferreira; Jorge Sequeiros; Isabel Alonso; Alda Sousa; Carolina Lemos
Journal:  Ann Clin Transl Neurol       Date:  2019-03-07       Impact factor: 4.511

Review 6.  Ocular Manifestations and Therapeutic Options in Patients with Familial Amyloid Polyneuropathy: A Systematic Review.

Authors:  A C Martins; A M Rosa; E Costa; C Tavares; M J Quadrado; J N Murta
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

7.  Vitreous Amyloidosis as the Presenting Symptom of Familial Amyloid Polyneuropathy TTR Val30Met in a Portuguese Patient.

Authors:  Mariana Seca; Natália Ferreira; Teresa Coelho
Journal:  Case Rep Ophthalmol       Date:  2014-03-15

8.  Epidemiology of transthyretin-associated familial amyloid polyneuropathy in the Majorcan area: Son Llàtzer Hospital descriptive study.

Authors:  Juan Buades Reinés; Tomás Ripoll Vera; Mercedes Uson Martín; Hernán Andréu Serra; Ma Margarita Company Campins; José Miguel Diéguez Millán; Cristina Gallego Lezaun; Manuel Raya Cruz
Journal:  Orphanet J Rare Dis       Date:  2014-02-26       Impact factor: 4.123

9.  Estimating the global prevalence of transthyretin familial amyloid polyneuropathy.

Authors:  Hartmut H Schmidt; Márcia Waddington-Cruz; Marc F Botteman; John A Carter; Avijeet S Chopra; Markay Hopps; Michelle Stewart; Shari Fallet; Leslie Amass
Journal:  Muscle Nerve       Date:  2018-02-01       Impact factor: 3.217

10.  Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy.

Authors:  Alejandra González-Duarte; Isabel Conceição; Leslie Amass; Marc F Botteman; John A Carter; Michelle Stewart
Journal:  Neurol Ther       Date:  2020-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.